Aurobindo Pharma | The company had reported 80 percent rise in consolidated net profit to Rs 909 crore in the Jan-March quarter of FY24 from Rs 508 crore in the same period a year ago.
USFDA classifies Aurobindo Pharma arm Eugia s mfg Unit III as official action indicated moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.
Drug maker Aurobindo Pharma on Saturday announced that the US Food and Drug Administration (FDA) has classified Eugia Pharma Specialities' (a wholly owned subsidiary of the company) formulation manufacturing facility Unit III, as 'Official .
The Telangana Real Estate Regulatory Authority (TSRERA) bench, consisting of Justice Dr. N. Satyanarayana (Chairperson), K. Srinivasa Rao (Member), and Laxmi Narayana Jannu (Member), has directed .